Zones No. of tested No. of DAT+ 95% CI sero-prevalence (%) North-west 31499 1877 5.7-6.2 6.0 North-east 3341 85 2.0-3.1 2.5 Central* 1431 88 4.9-7.4 6.1 South 4567 215 3.9-5.1 4.7 Total 40838 2265 5.3-5.7 5.5 *Majority of samples were only prepared from hospitalized patients.

Table 1: Sero-prevalence of human visceral Leishmania infection by direct agglutination test (DAT) with anti-Leishmania infantum antibodies at ≥1:3200 titers by geographical zones during 1996 -2010.